Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease

Canadian Journal of Physiology and Pharmacology

Volumn 89, Issue 4, 2011, Pages 239-244

  Bulut, Daniel ^a   Becker, Vanessa ^a   Mügge, Andreas ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

Acetylsalicylate; Coronary artery disease; Endothelial function; Endothelial progenitor cells; Flow mediated vasodilation; Microparticles; Platelet microparticles

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CD34 ANTIGEN; CYCLOOXYGENASE 2; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ETORICOXIB; GLYCERYL TRINITRATE; SIMVASTATIN; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DRUG EFFECT; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; FLOW MEDIATED VASODILATION; HUMAN; HYPEREMIA; MALE; NEUTROPHIL; PLATELET MICROPARTICLE; PRIORITY JOURNAL; TREATMENT DURATION;

ASPIRIN; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; CORONARY ARTERY DISEASE; CYCLOOXYGENASE 2 INHIBITORS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MALE; MIDDLE AGED; PYRIDINES; STEM CELLS; SULFONES; VASODILATION;

EID: 79960782018     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/y11-013     Document Type: Article

References (22)

1. Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., et al. 1999. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85(3): 221-228
2. Baigent, C., Blackwell, L., Collins, R., Emberson, J., Godwin, J., Peto, R., et al. Antithrombotic Trialists' (ATT) Collaboration. 2009. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet, 373(9678): 1849-1860. doi:10. 1016/S0140-6736(09)60503-1.
3. Boulanger, C.M., Scoazec, A., Ebrahimian, T., Henry, P., Mathieu, E., Tedgui, A., and Mallat, Z. 2001. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation, 104(22): 2649-2652. doi:10.1161/hc4701.100516.
4. Boulanger, C.M., Amabile, N., and Tedgui, A. 2006. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension, 48(2): 180-186. doi:10.1161/01.HYP.0000231507.00962.b5.
5. + microparticles in healthy offsprings of patients with coronary artery disease. Eur. J. Clin. Invest. 39(1): 17-22. doi:10.1111/j. 1365-2362.2008.02058.x.
6. Daleke, D.L. 2003. Regulation of transbilayer plasma membrane phospholipid asymmetry. J. Lipid Res. 44(2): 233-242. doi:10. 1194/jlr.R200019-JLR200
7. Dimmeler, S., and Zeiher, A.M. 2004. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J. Mol. Med. 82(10): 671-677. doi:10.1007/s00109-004-0580-x.
8. Elwood, P.C., Gallagher, A.M., Duthie, G.G., Mur, L.A., and Morgan, G. 2009. Aspirin, salicylates, and cancer. Lancet, 373 (9671): 1301-1309. doi:10.1016/S0140-6736(09)60243-9.
9. Goldstein, L.J., Gallagher, K.A., Bauer, S.M., Bauer, R.J., Baireddy, V., Liu, Z.J., et al. 2006. Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide. Stem Cells, 24(10): 2309-2318. doi:10.1634/stemcells.2006-0010.
10. Horstman, L.L., Jy, W., Jimenez, J.J., and Ahn, Y.S. 2004. Endothelial microparticles as markers of endothelial dysfunction. Front. Biosci. 9(1-3): 1118-1135. doi:10.2741/1270.
11. Kagawa, H., Nomura, S., Nagahama, M., Ozaki, Y., and Fukuhara, S. 2001. Effect of bezafibrate on soluble adhesion molecules and platelet activation markers in patients with connective tissue diseases and secondary hyperlipidemia. Clin. Appl. Thromb. Hemost. 7(2): 153-157. doi:10.1177/107602960100700213.
12. Khan, S.S., Solomon, M.A., and McCoy, J.P., Jr. 2005. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin. Cytom. 64(1): 1-8.
13. Leroyer, A.S., Tedgui, A., and Boulanger, C.M. 2008. Role of microparticles in atherothrombosis. J. Intern. Med. 263(5): 528-537. doi:10.1111/j.1365-2796.2008.01957.x.
14. Massa, M., Campanelli, R., Bonetti, E., Ferrario, M., Marinoni, B., and Rosti, V. 2009. Rapid and large increase of the frequency of circulating endothelial colony-forming cells (ECFCs) generating late outgrowth endothelial cells in patients with acute myocardial infarction. Exp. Hematol. 37(1): 8-9. doi:10.1016/j.exphem.2008.09.007.
15. Morel, O., Hugel, B., Jesel, L., Mallat, Z., Lanza, F., Douchet, M.P., et al. 2004. Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. J. Thromb. Haemost. 2(7): 1118-1126. doi:10.1111/j.1538-7836.2004.00805.x.
16. Pfister, S.L. 2004. Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery. Hypertension, 43(2): 428-433. doi:10.1161/01.HYP.0000110906.77479.91.
17. Schmidt-Lucke, C., Rössig, L., Fichtlscherer, S., Vasa, M., Britten, M., Kämper, U., et al. 2005. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation, 111(22): 2981-2987. doi:10.1161/CIRCULATIONAHA.104.504340.
18. Soriano, A.O., Jy, W., Chirinos, J.A., Valdivia, M.A., Velasquez, H. S., Jimenez, J.J., et al. 2005. Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis. Crit. Care Med. 33(11): 2540-2546. doi:10.1097/01.CCM. 0000186414.86162.03.
19. Tramontano, A.F., O'Leary, J., Black, A.D., Muniyappa, R., Cutaia, M.V., and El-Sherif, N. 2004. Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway. Biochem. Biophys. Res. Commun. 320(1): 34-38. doi:10.1016/j.bbrc.2004.05.127.
20. Valgimigli, M., Rigolin, G.M., Fucili, A., Porta, M.D., Soukhomovskaia, O., Malagutti, P., et al. 2004. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation, 110(10): 1209-1212. doi:10.1161/01.CIR.0000136813.89036.21
21. Vasa, M., Fichtlscherer, S., Adler, K., Aicher, A., Martin, H., Zeiher, A.M., and Dimmeler, S. 2001. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation, 103(24): 2885-2890. doi:10.1161/hc2401.092816.
22. Walther, C., Adams, V., Bothur, I., Drechsler, K., Fikenzer, S., Sonnabend, M., et al. 2008. Increasing physical education in high school students: effects on concentration of circulating endothelial progenitor cells. Eur. J. Cardiovasc. Prev. Rehabil. 15(4): 416-422. doi:10.1097/HJR.0b013e3282fb2df1.